Changes related to "Rituximab (Rituxan)"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 00:13, 23 June 2018
   
Page name:

22 June 2018

     22:38  Primary mediastinal B-cell lymphoma‎ (diff | hist) . . (+5,309). . Jwarner (talk | contribs) (R-CHOP {{#subobject:796753|Regimen=1}})
 m   22:32  Diffuse large B-cell lymphoma‎‎ (2 changes | history) . . (-927). . [Jwarner‎ (2×)]
 m    22:32 (cur | prev) . . (+49). . Jwarner (talk | contribs) (R-CHOP-14 {{#subobject:fc3bde|Regimen=1}})
 m    19:16 (cur | prev) . . (-976). . Jwarner (talk | contribs) (R-CVP {{#subobject:1b5df7|Regimen=1}})
 m   15:45  Post-transplant lymphoproliferative disorder‎ (diff | hist) . . (+14). . Jwarner (talk | contribs) (References)

21 June 2018

 m   23:02  Waldenström macroglobulinemia‎‎ (3 changes | history) . . (+5,169). . [Jwarner‎ (3×)]
 m    23:02 (cur | prev) . . (+1,499). . Jwarner (talk | contribs) (Rituximab monotherapy {{#subobject:067613|Regimen=1}})
 m    23:02 (cur | prev) . . (-1,499). . Jwarner (talk | contribs) (Ibrutinib & Rituximab {{#subobject:cd5899|Regimen=1}})
 m    23:01 (cur | prev) . . (+5,169). . Jwarner (talk | contribs)
     22:19  Follicular lymphoma‎‎ (2 changes | history) . . (+12,296). . [Jwarner‎ (2×)]
      22:19 (cur | prev) . . (+12,222). . Jwarner (talk | contribs)
 m    20:36 (cur | prev) . . (+74). . Jwarner (talk | contribs)

20 June 2018

 m   14:53  Diffuse large B-cell lymphoma‎‎ (3 changes | history) . . (+491). . [Jwarner‎ (3×)]
 m    14:53 (cur | prev) . . (+213). . Jwarner (talk | contribs)
 m    13:43 (cur | prev) . . (+2,393). . Jwarner (talk | contribs) (R-DHAP {{#subobject:18c266|Regimen=1}})
 m    13:37 (cur | prev) . . (-2,115). . Jwarner (talk | contribs) (ROAD {{#subobject:0d0c67|Regimen=1}})
 m   11:57  Mantle cell lymphoma‎ (diff | hist) . . (+105). . Jwarner (talk | contribs)
 m   11:53  Waldenström macroglobulinemia‎ (diff | hist) . . (+102). . Jwarner (talk | contribs)
 m   11:50  B-cell acute lymphoblastic leukemia‎ (diff | hist) . . (+32). . Jwarner (talk | contribs) (Chemoradiotherapy ("Course III"))
 m   11:33  CNS lymphoma‎ (diff | hist) . . (+49). . Jwarner (talk | contribs) (Upfront therapy, non-randomized or retrospective data)
 m   10:38  Follicular lymphoma‎ (diff | hist) . . (-3,669). . Jwarner (talk | contribs)

19 June 2018

 m   22:51  Waldenström macroglobulinemia‎ (diff | hist) . . (+43). . Jwarner (talk | contribs)
 m   22:49  Marginal zone lymphoma‎ (diff | hist) . . (+57). . Jwarner (talk | contribs) (Fludarabine & Rituximab {{#subobject:413f96|Regimen=1}})
 m   22:46  Follicular lymphoma‎‎ (2 changes | history) . . (+42). . [Jwarner‎ (2×)]
 m    22:46 (cur | prev) . . (-16). . Jwarner (talk | contribs)
 m    22:45 (cur | prev) . . (+58). . Jwarner (talk | contribs) (Advanced disease, first-line therapy, non-randomized or retrospective data)
 m   22:42  Cold agglutinin disease‎ (diff | hist) . . (+119). . Jwarner (talk | contribs) (Fludarabine & Rituximab {{#subobject:96c221|Regimen=1}})
 m   17:49  Chronic lymphocytic leukemia (CLL/SLL)‎ (diff | hist) . . (+11). . Jwarner (talk | contribs)
 m   17:36  HIV-associated lymphoma‎‎ (2 changes | history) . . (+195). . [Jwarner‎ (2×)]
 m    17:36 (cur | prev) . . (+2,688). . Jwarner (talk | contribs) (Upfront therapy)
 m    17:35 (cur | prev) . . (-2,493). . Jwarner (talk | contribs) (DR-COP {{#subobject:ec091e|Regimen=1}})
 m   17:05  CNS lymphoma‎ (diff | hist) . . (-171). . Jwarner (talk | contribs)

18 June 2018

 m   20:56  Hodgkin lymphoma‎‎ (2 changes | history) . . (+148). . [Jwarner‎ (2×)]
 m    20:56 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Subsequent treatment)
 m    20:55 (cur | prev) . . (+144). . Jwarner (talk | contribs) (Consolidation after upfront therapy)
 m   20:48  Follicular lymphoma‎‎ (3 changes | history) . . (-2,875). . [Jwarner‎ (3×)]
 m    20:48 (cur | prev) . . (+431). . Jwarner (talk | contribs) (BVR {{#subobject:ad1aa9|Regimen=1}})
 m    20:43 (cur | prev) . . (-3,314). . Jwarner (talk | contribs) (VBR {{#subobject:bdecdf|Regimen=1}})
 m    17:48 (cur | prev) . . (+8). . Jwarner (talk | contribs)
 m   17:52  Waldenström macroglobulinemia‎ (diff | hist) . . (+81). . Jwarner (talk | contribs)
 m   17:27  Chronic lymphocytic leukemia (CLL/SLL)‎‎ (5 changes | history) . . (-3,648). . [Jwarner‎ (5×)]
 m    17:27 (cur | prev) . . (+147). . Jwarner (talk | contribs) (BendOfa {{#subobject:4eab04|Regimen=1}})
 m    17:24 (cur | prev) . . (+2,297). . Jwarner (talk | contribs) (CFAR {{#subobject:30ac6b|Regimen=1}})
 m    17:23 (cur | prev) . . (-2,273). . Jwarner (talk | contribs) (G-B {{#subobject:e26569|Regimen=1}})
 m    11:38 (cur | prev) . . (+21). . Jwarner (talk | contribs) (Placebo)
 m    11:27 (cur | prev) . . (-3,840). . Jwarner (talk | contribs) (Lenalidomide monotherapy {{#subobject:9820ba|Regimen=1}})
 m   13:36  Hodgkin lymphoma, nodular lymphocyte-predominant‎ (diff | hist) . . (-175). . Jwarner (talk | contribs) (ABVD {{#subobject:4c2988|Regimen=1}})

17 June 2018

 m   20:33  Hodgkin lymphoma‎‎ (2 changes | history) . . (+3,054). . [Jwarner‎ (2×)]
 m    20:33 (cur | prev) . . (+2,141). . Jwarner (talk | contribs) (ABVD {{#subobject:8b9772|Regimen=1}})
 m    20:19 (cur | prev) . . (+913). . Jwarner (talk | contribs) (Escalated BEACOPP {{#subobject:ca99d7|Regimen=1}})